Philogen S.p.A.

€21.15As of Sun 8 Nov 2026, 12:00 UTC
BIT:PHILHealthcare
Country Italy
PE (Fwd) •••
TSR 6Y CAGR 6.47%
Div yield 3.31%
ROE 98.35%
Biotechnology
Beta (5Y) —
PE TTM 3.800
TSR TTM (11.98%)
Mkt cap €851.3M
ROIC 64.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€25
16.07%
36.96%
Hold 4|3|11|11|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.19
0.19
0.20
0.20
2.99%
(1.77%)
8.86%
8.83%
Revenue€M
105.2
103.9
105.8
104.4
2.82%
(0.79%)
0.50%
0.68%
Peers (US$955.8M)
Cap (US$)
PE
12.25B
22.38x
799.9M
34.36x
Capital
TTM
5Y
10Y
Leveragex
0.368
0.206
0.166
EBIT/Intx
16.82
0.493
0.529
Own earn%
(47.40)
2.44
(4.11)
Sh yield%
30.55
28.97
29.51
Owners
Insiders/Inst%
11.57
81.22
Short interest%
2.00
SBC / revenue%
2.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
20–26
$1 testx
5.6
Incr. ROIC%
22